AZISAST Study: AZIthromycin in Severe ASThma Study

NCT00760838 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

109

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: Azithromycin 250 mg
DRUG: Placebo

Sponsor

University Hospital, Ghent

Collaborators

[object Object]